Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis.
Paolo PreziosaElisabetta PaganiLucia MoiolaMariaemma RodegherMassimo FilippiMaria Assunta RoccaPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)
The effects of natalizumab and fingolimod on SEL occurrence seem modest, with natalizumab being slightly more effective. Both treatments may promote reparative mechanisms in stable or chronic inactive lesions.